Clinical updates, including trial initiations, enrollment status and data readouts and publications: Autolus, Galderma, Gilead, Hua, Maplight, Merus, MBX, Revolution Medicines, Senti, Soligenix.

Regulatory snapshots, including global drug submissions and approvals, clinical trial approvals and other regulatory decisions and designations: Advanz, Anavex, Aop Orphan, Beigene, Cevomed, Exelixis, Gsk, Kelun-Biotech, Lin, Novartis, Oncopeptides, Satsuma, Tuhura, Valneva.

Biopharmas raising money in public or private financings, including: Secretome, Transcode.

New hires and promotions in the biopharma industry, including: Biogene, Fate, Preveceutical, Senti.

Clinical updates, including trial initiations, enrollment status and data readouts and publications: Alector, PTC, Outlook.

Biopharma happenings, including deals and partnerships, grants, preclinical data and other news in brief: Acadia, Adcendo, Agenus, Alector, Duality Biologics, Empyrean, Eos, Idorsia, Kronos, PTC, Saniona.

A quick look back at top stories.

The top 10 biopharma stock gainers and losers for the week.

BioWorld's offices were closed in observance of Thanksgiving in the U.S. No issues were published Thursday, Nov. 28, or Friday, Nov. 29.